These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 9566199)
1. The crystal structure of bikunin from the inter-alpha-inhibitor complex: a serine protease inhibitor with two Kunitz domains. Xu Y; Carr PD; Guss JM; Ollis DL J Mol Biol; 1998 Mar; 276(5):955-66. PubMed ID: 9566199 [TBL] [Abstract][Full Text] [Related]
2. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures. Krystek S; Stouch T; Novotny J J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666 [TBL] [Abstract][Full Text] [Related]
3. Kunitz-type soybean trypsin inhibitor revisited: refined structure of its complex with porcine trypsin reveals an insight into the interaction between a homologous inhibitor from Erythrina caffra and tissue-type plasminogen activator. Song HK; Suh SW J Mol Biol; 1998 Jan; 275(2):347-63. PubMed ID: 9466914 [TBL] [Abstract][Full Text] [Related]
4. Crystal structure of cancer chemopreventive Bowman-Birk inhibitor in ternary complex with bovine trypsin at 2.3 A resolution. Structural basis of Janus-faced serine protease inhibitor specificity. Koepke J; Ermler U; Warkentin E; Wenzl G; Flecker P J Mol Biol; 2000 May; 298(3):477-91. PubMed ID: 10772864 [TBL] [Abstract][Full Text] [Related]
5. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin. Azim MK; Grossmann JG; Zaidi ZH J Nat Toxins; 1999 Oct; 8(3):363-84. PubMed ID: 10591040 [TBL] [Abstract][Full Text] [Related]
6. Conformational lability in serine protease active sites: structures of hepatocyte growth factor activator (HGFA) alone and with the inhibitory domain from HGFA inhibitor-1B. Shia S; Stamos J; Kirchhofer D; Fan B; Wu J; Corpuz RT; Santell L; Lazarus RA; Eigenbrot C J Mol Biol; 2005 Mar; 346(5):1335-49. PubMed ID: 15713485 [TBL] [Abstract][Full Text] [Related]
7. Compromise and accommodation in ecotin, a dimeric macromolecular inhibitor of serine proteases. Gillmor SA; Takeuchi T; Yang SQ; Craik CS; Fletterick RJ J Mol Biol; 2000 Jun; 299(4):993-1003. PubMed ID: 10843853 [TBL] [Abstract][Full Text] [Related]
8. Mouse hepatocyte growth factor (HGF) activator inhibitor type 2 lacking the first Kunitz domain potently inhibits the HGF activator. Kataoka H; Itoh H; Nuki Y; Hamasuna R; Naganuma S; Kitamura N; Shimomura T Biochem Biophys Res Commun; 2002 Jan; 290(3):1096-100. PubMed ID: 11798188 [TBL] [Abstract][Full Text] [Related]
9. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases. Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824 [TBL] [Abstract][Full Text] [Related]
10. Bikunin prevents adhesion of calcium oxalate crystal to renal tubular cells in human urine. Ebisuno S; Nishihata M; Inagaki T; Umehara M; Kohjimoto Y J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S436-40. PubMed ID: 10541279 [TBL] [Abstract][Full Text] [Related]
11. Inter-alpha-inhibitor: a protein family involved in the inhibition of calcium oxalate crystallization. Atmani F; Mizon J; Khan SR Scanning Microsc; 1996; 10(2):425-33; discussion 433-4. PubMed ID: 9813621 [TBL] [Abstract][Full Text] [Related]
12. The ornithodorin-thrombin crystal structure, a key to the TAP enigma? van de Locht A; Stubbs MT; Bode W; Friedrich T; Bollschweiler C; Höffken W; Huber R EMBO J; 1996 Nov; 15(22):6011-7. PubMed ID: 8947023 [TBL] [Abstract][Full Text] [Related]
13. Atypical Kunitz-type serine proteinase inhibitors produced by the ruminant placenta. MacLean JA; Roberts RM; Green JA Biol Reprod; 2004 Aug; 71(2):455-63. PubMed ID: 15070828 [TBL] [Abstract][Full Text] [Related]
14. Role of urinary bikunin in the inhibition of calcium oxalate crystallization. Atmani F; Khan SR J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269 [TBL] [Abstract][Full Text] [Related]
15. Effects of inter-alpha-inhibitor and several of its derivatives on calcium oxalate crystallization in vitro. Dean C; Kanellos J; Pham H; Gomes M; Oates A; Grover P; Ryall R Clin Sci (Lond); 2000 Apr; 98(4):471-80. PubMed ID: 10731483 [TBL] [Abstract][Full Text] [Related]
16. Extended intermolecular interactions in a serine protease-canonical inhibitor complex account for strong and highly specific inhibition. Fodor K; Harmat V; Hetényi C; Kardos J; Antal J; Perczel A; Patthy A; Katona G; Gráf L J Mol Biol; 2005 Jul; 350(1):156-69. PubMed ID: 15922357 [TBL] [Abstract][Full Text] [Related]
17. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant. Zhang E; St Charles R; Tulinsky A J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787 [TBL] [Abstract][Full Text] [Related]
18. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site. Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354 [TBL] [Abstract][Full Text] [Related]
20. [Proteins of the inter-alpha trypsin inhibitor (ITI) family. A major role in the biology of the extracellular matrix]. Cuvelier A; Muir JF; Martin JP; Sesboüé R Rev Mal Respir; 2000 Apr; 17(2):437-46. PubMed ID: 10859762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]